Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG Vaccination to Reduce Early Infant Mortality
NCT02504203Phase 4Terminated
- Sponsor
- Bandim Health Project
- Start
- Nov 2015
- Primary completion
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of bcg vaccine in Infant mortality (IMR), sponsored by Bandim Health Project. Started Nov 2015; status: terminated.
02
Drugs
bcg vaccine
03
Conditions
Infant mortality (IMR)
Beyond the preview
Go deeper on NCT02504203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02504203.